The Efficacy and Safety of Bedaquiline in the Treatment of Pulmonary Tuberculosis Patients: A Systematic Review and Meta-Analysis

Background: Bedaquiline (BDQ) has been designated as a Group A drug by the World Health Organization (WHO) for the management of multi-drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). This systematic review and meta-analysis aim to evaluate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Enyu, Wu, Qian, Chen, Yiming, Liu, Zhengwei, Zhang, Mingwu, Zhu, Yelei, Wu, Kunyang, Pan, Junhang, Jiang, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525131/
https://www.ncbi.nlm.nih.gov/pubmed/37760686
http://dx.doi.org/10.3390/antibiotics12091389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525131/
https://www.ncbi.nlm.nih.gov/pubmed/37760686
http://dx.doi.org/10.3390/antibiotics12091389

Ejemplares similares